The specific aims of this proposal are to determine the mechanisms of hormone, autocoid and drug regulation of the isoenzyme forms of guanylate cyclase and cyclic GMP synthesis. The precise mechanisms involved in hormone receptor coupling to the different guanylate cyclase isoenzymes will be examined in considerable detail. Experiments will utilize intacts cell cultures and tissues as well as crude and purified components and their reconstitution in cell-free preparations. The effects of atrial natriuretic factor and E. coli heat-stable enterotoxin on cyclic GMP synthesis as well as other ligands and hormones will serve as models and prototypes for these studies. The effects of ATP and other nucleotides and a recently purified protein activator of guanylate cyclase will also be examined. The role of these materials as well as protein phosphorylation and dephosphorylation in guanylate cyclase regulation and hormone coupling to cyclic GMP synthesis will be examined. Methods will include the purification and characterization of coupling factors for hormonal regulation of guanylate cyclase and their functional reconstitution. These studies are expected to increase our understanding of the role of cyclic GMP as a fundamental second messenger to mediate hormone effects and, thus, should provide mechanisms to modify biochemical and physiological responses in normal and pathological states.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030787-11
Application #
3229644
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1989-06-01
Project End
1992-05-31
Budget Start
1991-08-01
Budget End
1992-05-31
Support Year
11
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Abbott Laboratories
Department
Type
DUNS #
City
North Chicago
State
IL
Country
United States
Zip Code
60064
Sheng, H; Ishii, K; Forstermann, U et al. (1995) Mechanism of bradykinin-induced cyclic GMP accumulation in bovine tracheal smooth muscle. Lung 173:373-83
Nakane, M; Schmidt, H H; Pollock, J S et al. (1993) Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316:175-80
Pollock, J S; Nakane, M; Buttery, L D et al. (1993) Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 265:C1379-87
Sheng, H; Gagne, G D; Matsumoto, T et al. (1993) Nitric oxide synthase in bovine superior cervical ganglion. J Neurochem 61:1120-6
Schmidt, H H; Gagne, G D; Nakane, M et al. (1992) Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem 40:1439-56
Pollock, J S; Klinghofer, V; Forstermann, U et al. (1992) Endothelial nitric oxide synthase is myristylated. FEBS Lett 309:402-4
Mitchell, J A; Kohlhaas, K L; Matsumoto, T et al. (1992) Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages. Mol Pharmacol 41:1163-8
Warner, T D; Budzik, G P; Matsumoto, T et al. (1992) Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA. Br J Pharmacol 106:948-52
Klabunde, R E; Kimber, N D; Kuk, J E et al. (1992) NG-methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro. Eur J Pharmacol 223:1-7
Schmidt, H H; Smith, R M; Nakane, M et al. (1992) Ca2+/calmodulin-dependent NO synthase type I: a biopteroflavoprotein with Ca2+/calmodulin-independent diaphorase and reductase activities. Biochemistry 31:3243-9

Showing the most recent 10 out of 37 publications